Member Info for Bestmate

Hopefully today marks the first step towards completion of the transaction we have all been waiting for. Market doesn’t know how to price this, so some have offloaded to a total of 1.8 million this am. I’m a buyer this morning as the ask is in the year low and I think/hope we will correct on the run up to admission on AIM, and further positive news.

no problem koolkat15, like a lot here i’m down a fair bit, especially after topping another 1 million shares this week. i didn’t take the 150k profit when it was at the high, so my exit strategy was pants, so had to double down just out of spite. either way, i would reiterate people should email ronjon and get personal with him, as he’s definitely on this one and not here for ****s and giggles

Overall, the presentation was targeting potential new Investors, so in that respect it was very Informative and detailed in explaining what capAI is about. Obviously, the stalwarts on this board want more meat on the bone, so maybe a bit more regurgitated than dynamic for them. In terms of Ronjons perception of where the company lies in Commercial value; he stated that we are at the ground floor, and it was a good entry level for Investment. I think he spent a fair amount of time on the Longevity angle, and highlighted that Big Pharma don’t really have AI at the forefront of their operational systems and set up, so maybe there is an opportunity here for a tie up once we know the Utility of CapMed. He also mentioned that there would be Stategic Partenerships in the future, so could be further R42 or beyond joint ventures. I think we are very much so in the nursery stages of development as a Commercial Entity, and this may not suit many people’s agendas who are expecting Revenue expansion now. However, he made a very valid point about how many AI companies lose billions regularly as the race in the US sector is more about throwing millions into Concept and if they fail you take the hit. The whole Silicon Valley set up is about big Mergers and that’s where you can cash in if you hit the AI concept nail on the head. Ronjon has the vision and the experience, so I ask myself why is he spending a lot of his energy on promoting a small cap like capAl, when he could pay safe in an arena where he can dominate; well he clearly said that their is Investment shut off in the USA, whereas the LSE at least allows liquidity and a potential for an exit strategy. My only hang was if Ronjon really understands the complexities and hooks of the LSE and all its patrons, the fact that it is such a manipulated and fickle market. He is also an Investor as well as in Operations, so at least he is putting his money down and has skin in the game, as well as not drawing a salary. Revenue generation of course is important to back up proof of concept, but I still feel we can hit the ground running if a standout project can gain momentum and exposure. My money is on longevity, but the content side of things is still highly lucrative if the right people want a piece of the action.

Sadly that appears to be the case…

Koolkat, Ronjon is extremely passionate and serious about his role at CapAI.. if anyone is in any doubt as to his loyalty to this company, I suggest they reach out to him on Linkedin. Of course we all know his credentials speak for themselves, but he still has it all to do here and that is the risk reward factor. We are around 85/90% down from the highs of last year, so very unlikely many are sitting on paper profits. This presentation wasn’t really promoted by him, but it was important enough to be news released via Newswire and OTC.. all I can say is that this will probably not be the last time CPAI will be showcasing, in particular the USA, and we don’t get an early heads up. The game is beginning, and those who have written it off and are thinking nothing doing this year, have a right to their opinion. It’s an Insiders game, when the right peoples money is down, nobody will be talking about outstanding warrants.

Hilarious.. still gives us something to talk about

Yes, I thought I’d disrupt the countdown with a 400k buy at 1.03

Interesting that CapAI is presenting tomorrow at this online conference. Some of the fellow Presenting companies have interesting profiles. So regardless of the usual banter on here, Ronjon is chipping away at what needs to be done here to put this company on the map. Just a reminder of who he is and who is potential contacts and Investors might be. It’s a pan American event, that was announced via the news service on the OTC. Are we now setting the scene for a serious PR drive in the USA with the medical side of the R42 tie up.. Ronjon does not have time to waste

Yes, delayed buy print of £9500

When it was NT to buy for twenty minutes at 0.0775, the delayed 25,633,985 was being worked.. after that it moved up to 0.0825 to buy. MMs doing there thing

Looks like the 15 million delayed sell print dragged the sp down..

Strange trading pattern here today; initially raising bid on each sell up to 0.087, with ask still at 0.0874.. might see some interesting scenarios here later

No discount; advertised ask at the time was 0.0279 to buy.. so 2 tranches both bought at 0.0288. Also now can sell 15,000,0000, so a bit of liquidity back for now. Obviously, not groundbreaking, but when CLON goes on a run, we will see a good amount of these trades as per historically known about this stock.

Someone’s helping themselves to 20,000,000 clips at premium

No problem, Alboumphoto..

Hard to say what my current status on this stock is; I sold a few here and there around 0.4, 0.5 and very few at 0.8. Then buying again post consolidation, now down around 50% on those tranches, so I would say a fair bit in the red. Either way, it’s a different Investment now as the initial hype of Ronjon has obviously tapered off. The historical warrants issue has killed any momentum post Consolidation, but that was probably to be expected on the balance of the shenanigans pre CPAI. I’m not really too bothered about revenue figures, because they will have associated fixed costs attached to them, albeit reduced due to the perceived efficiencies of small teams trying to build Unicorns. All I know is, I work closely with AI hubs in Industry, and it hasn’t even taken off yet. Just like everyone else here, my money is on Ronjon, and him pulling off one Unicorn, be it in Literature, Media or Medical from his list of mergers into CPAI. Yes, I could have made a decent amount if I sold into the highs of last year, but we are all long termers now.. everything to play for in my opinion only.

Ridiculous buy limit in place here; only £1000 available at 1.79, and then NT to buy. MMs playing a blinder (not) to create false trading narrative. Positive side; raise the bid and allow buying.. then see what happens

My first purchase was around 0.04 post Dukemont. After the Ronjon RNS the SP rose to near 0.9. So the increase in that period was in excess of 2000%; this is factual.

After consolidation, we were around 0.3p equivalent, so we are 60% down from then, or in old money 90% down from the highs of last year

Yes, purchasing above 0.03 would indicate a reversal, if it can hold.. will the buyers show their hand today

Nice 33,333,333 buy at 0.03 premium